Growth Metrics

Ocugen (OCGN) Change in Accured Expenses (2014 - 2026)

Ocugen posted quarterly Change in Accured Expenses of -$5.4 million for Q1 2026, down 65.18% year-on-year from -$15.5 million in Q1 2025, and down 547.6% on a QoQ basis from $1.2 million in Q4 2025.

Ocugen (OCGN) has 13 years of Change in Accured Expenses data on file, last reported at -$5.4 million in Q1 2026.

  • For the quarter ending Q1 2026, Change in Accured Expenses fell 65.18% year-over-year to -$5.4 million; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (down 48.98% YoY), and the FY2025 full-year result was $3.3 million, down 19.97% from the prior year.
  • Change in Accured Expenses for Q1 2026 stood at -$5.4 million, down from $1.2 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $3.9 million in Q3 2022 and bottomed at -$5.4 million in Q1 2026.
  • The 5-year median for Change in Accured Expenses is $1.2 million (2025), against an average of -$47411.8.
  • The widest annual swing landed in 2022, when Change in Accured Expenses soared 380.45%; it then tumbled 3889.31% in 2023.
  • A 5-year view of Change in Accured Expenses shows it stood at $2.8 million in 2022, then sank by 170.5% to -$1.9 million in 2023, then jumped by 207.62% to $2.1 million in 2024, then sank by 42.27% to $1.2 million in 2025, then tumbled by 547.6% to -$5.4 million in 2026.
  • The last three Change in Accured Expenses figures came in at -$5.4 million (Q1 2026), $1.2 million (Q4 2025), and $3.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - 931,000.00
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 70.50 Mn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 107.70 Mn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn -176.03 Mn
10 Ocugen 452.01 Mn 452.01 Mn - -5.40 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -5.40 Mn
Mar 31, 2026 -5.40 Mn
Dec 31, 2025 1.21 Mn
Dec 31, 2025 1.21 Mn
Sep 30, 2025 3.29 Mn
Sep 30, 2025 3.29 Mn
Jun 30, 2025 2.08 Mn
Jun 30, 2025 2.08 Mn
Mar 31, 2025 -3.27 Mn
Mar 31, 2025 -3.27 Mn
Dec 31, 2024 2.09 Mn
Dec 31, 2024 2.09 Mn
Sep 30, 2024 2.16 Mn
Sep 30, 2024 2.16 Mn
Jun 30, 2024 1.33 Mn
Jun 30, 2024 1.33 Mn
Mar 31, 2024 -1.45 Mn
Mar 31, 2024 -1.45 Mn
Dec 31, 2023 -1.94 Mn
Dec 31, 2023 -1.94 Mn
Sep 30, 2023 -1.35 Mn
Sep 30, 2023 -1.35 Mn
Jun 30, 2023 -4.09 Mn
Jun 30, 2023 -4.09 Mn
Mar 31, 2023 -4.96 Mn
Mar 31, 2023 -4.96 Mn
Dec 31, 2022 2.75 Mn
Dec 31, 2022 2.75 Mn
Sep 30, 2022 3.89 Mn
Sep 30, 2022 3.89 Mn
Jun 30, 2022 2.71 Mn
Jun 30, 2022 2.71 Mn
Mar 31, 2022 131,000.00
Mar 31, 2022 131,000.00
Dec 31, 2021 573,000.00
Dec 31, 2021 573,000.00
Sep 30, 2021 1.44 Mn
Sep 30, 2021 1.44 Mn
Jun 30, 2021 1.08 Mn
Jun 30, 2021 1.08 Mn
Mar 31, 2021 405,000.00
Mar 31, 2021 405,000.00
Dec 31, 2020 592,000.00
Dec 31, 2020 592,000.00
Sep 30, 2020 87,000.00
Sep 30, 2020 87,000.00
Jun 30, 2020 5,000.00
Jun 30, 2020 5,000.00
Mar 31, 2020 -1.23 Mn
Mar 31, 2020 -1.23 Mn
Dec 31, 2019 -3.67 Mn
Dec 31, 2019 -3.67 Mn
Sep 30, 2019 1.39 Mn
Sep 30, 2019 1.39 Mn
Jun 30, 2019 -1.07 Mn
Jun 30, 2019 -1.07 Mn
Mar 31, 2019 1.72 Mn
Mar 31, 2019 1.72 Mn
Dec 31, 2018 2.22 Mn
Dec 31, 2018 2.22 Mn
Sep 30, 2018 2.48 Mn
Sep 30, 2018 2.48 Mn
Jun 30, 2018 538,000.00
Jun 30, 2018 538,000.00
Mar 31, 2018 -1.61 Mn
Mar 31, 2018 -1.61 Mn
Dec 31, 2017 1.10 Mn
Dec 31, 2017 1.10 Mn
Sep 30, 2017 125,000.00
Sep 30, 2017 125,000.00
Jun 30, 2017 400,000.00
Jun 30, 2017 400,000.00
Mar 31, 2017 -1.10 Mn
Mar 31, 2017 -1.10 Mn
Dec 31, 2016 613,000.00
Dec 31, 2016 613,000.00
Sep 30, 2016 -702,000.00
Sep 30, 2016 -702,000.00
Jun 30, 2016 1.21 Mn
Jun 30, 2016 1.21 Mn
Mar 31, 2016 -463,000.00
Mar 31, 2016 -463,000.00
Dec 31, 2015 -772,000.00
Dec 31, 2015 -772,000.00
Sep 30, 2015 3.34 Mn
Sep 30, 2015 3.34 Mn
Jun 30, 2015 -1.34 Mn
Jun 30, 2015 -1.34 Mn
Mar 31, 2015 317,000.00
Mar 31, 2015 317,000.00
Dec 31, 2014 54,000.00
Dec 31, 2014 54,000.00
Sep 30, 2014 -47,000.00
Sep 30, 2014 -47,000.00
Jun 30, 2014 879,000.00
Jun 30, 2014 879,000.00
Mar 31, 2014 -238,000.00
Mar 31, 2014 -238,000.00